Document Detail

Effects of anatabine and unilateral maximal eccentric isokinetic muscle actions on serum markers of muscle damage and inflammation.
MedLine Citation:
PMID:  24509134     Owner:  NLM     Status:  Publisher    
The purpose of this study was to examine the effects of anatabine supplementation in conjunction with unilateral, maximal eccentric isokinetic muscle actions on serum markers of muscle damage and pro-inflammatory cytokines in humans. Seventeen men (mean ± S.D. age = 22.4 ± 3.2 yrs) participated in this double-blinded, placebo-controlled, crossover study. Participants were randomly assigned to two 10-day conditions (anatabine and placebo) separated by a 2-4 week washout period. After seven days of supplementation, blood was sampled immediately prior to (PRE), immediately following (POST), and 24, 48, and 72h after 6 sets of 10 repetitions of unilateral, maximal eccentric isokinetic forearm flexion exercise. Concentrations of serum creatine kinase, lactate dehydrogenase, myoglobin, high sensitivity c-reactive protein, and TNF-α were measured. Creatine kinase, myoglobin, and lactate dehydrogenase increased (P<0.05), while high sensitivity c-reactive protein and TNF-α did not change (P>0.05) after the eccentric exercise during both conditions. Lactate dehydrogenase was higher (P<0.05) during the anatabine condition. The primary findings of this study were two-fold: (a) anatabine had no beneficial effects on traditional markers of muscle damage (creatine kinase, lactate dehydrogenase, and myoglobin) compared to placebo after the eccentric exercise protocol, and (b) the eccentric exercise protocol did not elicit increases in the pro-inflammatory cytokines (c-reactive protein and TNF-α). Future studies are needed to examine the effects of anatabine on naturally-occurring inflammation that is common with aging or obesity. Furthermore, additional research is needed to examine the relationship between muscle damage and inflammation after eccentric exercises of different mode, duration, and intensity.
Nathaniel D M Jenkins; Terry J Housh; Kristen C Cochrane; Haley C Bergstrom; Daniel A Traylor; Robert W Lewis; Samuel L Buckner; Richard J Schmidt; Glen O Johnson; Joel T Cramer
Related Documents :
16840584 - Cell-free plasma dna as a novel marker of aseptic inflammation severity related to exer...
23205324 - A delphi consensus approach to challenging case scenarios in moderate-to-severe psorias...
24663004 - Thermoregulatory responses in wheelchair tennis players: a pilot study.
8409084 - Responses of plasma magnesium and other cations to fluid replacement during exercise.
1993784 - Prediction of the frequency and duration of ambulatory myocardial ischemia in patients ...
23066524 - Component analysis of simple span vs. complex span adaptive working memory exercises: a...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-2-6
Journal Detail:
Title:  European journal of pharmacology     Volume:  -     ISSN:  1879-0712     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2014 Feb 
Date Detail:
Created Date:  2014-2-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier B.V. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inf...
Next Document:  Plastic surgery residency websites: a critical analysis of accessibility and content.